Share Price and Basic Stock Data
Last Updated: January 3, 2026, 12:29 pm
| PEG Ratio | -18.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
SRF Ltd, operating in the chemicals sector, recorded a market capitalization of ₹90,691 Cr and a share price of ₹3,060. The company’s revenue from operations for the fiscal year ending March 2025 stood at ₹14,693 Cr, reflecting a growth from ₹14,870 Cr in March 2023. Over the past few quarters, sales figures have fluctuated, with the most recent quarter (Sep 2023) reporting ₹3,177 Cr, down from ₹3,778 Cr in Mar 2023. This trend indicates a degree of volatility in demand or potential operational challenges. However, the company has shown resilience with a trailing twelve-month (TTM) revenue of ₹15,263 Cr, which surpasses its historical performance, indicating an upward trajectory in its business operations. The overall sales growth from ₹4,018 Cr in March 2014 to ₹14,693 Cr in March 2025 illustrates a robust long-term growth strategy that has effectively capitalized on market opportunities in the specialty chemicals domain.
Profitability and Efficiency Metrics
SRF Ltd’s profitability metrics depict a mixed performance. The operating profit margin (OPM) for the fiscal year 2025 was recorded at 18%, a decline from 24% in March 2023, indicating tightening margins amidst rising costs or competitive pressures. The net profit for the same period stood at ₹1,251 Cr, down from ₹2,162 Cr in March 2023. This decline is compounded by a tax rate of 27% for the fiscal year 2025, which may have impacted the net earnings. The interest coverage ratio (ICR) of 7.58x signifies that the company can comfortably meet its interest obligations, bolstering its financial stability. Additionally, the return on equity (ROE) was 9.90%, which, while lower than industry averages, still reflects effective utilization of shareholder funds. The cash conversion cycle (CCC) was recorded at 55 days, indicating efficient management of working capital, although the inventory turnover ratio of 6.29x suggests room for improvement in inventory management practices.
Balance Sheet Strength and Financial Ratios
SRF Ltd’s balance sheet reflects a solid financial foundation, with total assets amounting to ₹21,521 Cr and total liabilities at ₹21,521 Cr. The company’s reserves have steadily increased to ₹12,966 Cr as of September 2025, showcasing a strong ability to retain earnings and bolster equity. Borrowings stood at ₹4,605 Cr, resulting in a low long-term debt to equity ratio of 0.15, indicating prudent leverage management. The price-to-book value (P/BV) ratio was recorded at 6.92x, suggesting that the market values the company’s equity significantly higher than its book value, reflecting investor confidence in growth prospects. Furthermore, the current ratio of 1.13 indicates that SRF Ltd maintains adequate liquidity to cover short-term obligations, while a quick ratio of 0.69 suggests a reliance on inventory for liquidity. These metrics underscore the balance sheet’s strength, although the high P/BV could indicate an overvaluation relative to book assets.
Shareholding Pattern and Investor Confidence
The shareholding pattern of SRF Ltd reveals a balanced distribution of ownership, with promoters holding 50.26% of the shares, indicative of stable management control. Foreign institutional investors (FIIs) accounted for 17.98%, while domestic institutional investors (DIIs) held 19.53%, reflecting significant institutional interest in the company. The public shareholding stood at 12.20%, which is lower compared to typical sector norms, suggesting a concentrated ownership structure. The number of shareholders has decreased to 191,991 from 263,328 in December 2022, indicating a potential consolidation of investor interest or a shift in market sentiment. This decline in shareholder numbers could raise concerns about liquidity in the stock. However, the consistent interest from institutional investors may provide a cushion against volatility, showcasing confidence in the company’s long-term growth strategy despite recent challenges in profitability.
Outlook, Risks, and Final Insight
Looking ahead, SRF Ltd’s growth trajectory appears solid, supported by a strong balance sheet and institutional backing. However, risks remain, particularly concerning profitability pressures illustrated by declining margins and net profit. The cyclical nature of the chemicals industry may expose the company to fluctuations in raw material costs and demand variability. Furthermore, a high dependency on a limited number of products could pose challenges in diversifying revenue streams. Therefore, while SRF Ltd has the potential for sustained growth through strategic initiatives and operational efficiencies, it must navigate these risks carefully. Investors should monitor the company’s ability to maintain margins and manage costs effectively. If SRF can leverage its established market position and improve efficiency, it may well enhance its profitability and shareholder value in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 258 Cr. | 264 | 514/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.8 Cr. | 63.7 | 90.0/56.0 | 14.6 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,030 Cr. | 76.0 | 97.8/64.9 | 12.9 | 121 | 1.05 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 951 Cr. | 106 | 130/63.6 | 9.50 | 109 | 1.14 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 90,691 Cr. | 3,060 | 3,325/2,260 | 56.1 | 447 | 0.24 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,582.22 Cr | 1,169.39 | 33.11 | 204.33 | 0.41% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,728 | 3,470 | 3,778 | 3,338 | 3,177 | 3,053 | 3,570 | 3,464 | 3,424 | 3,491 | 4,313 | 3,819 | 3,640 |
| Expenses | 2,959 | 2,636 | 2,846 | 2,642 | 2,551 | 2,487 | 2,874 | 2,861 | 2,886 | 2,872 | 3,356 | 2,989 | 2,866 |
| Operating Profit | 769 | 834 | 932 | 696 | 626 | 566 | 696 | 603 | 538 | 620 | 957 | 830 | 774 |
| OPM % | 21% | 24% | 25% | 21% | 20% | 19% | 19% | 17% | 16% | 18% | 22% | 22% | 21% |
| Other Income | 33 | 10 | 22 | 12 | 29 | 19 | 23 | 25 | 33 | 40 | 34 | 29 | 26 |
| Interest | 44 | 62 | 66 | 66 | 79 | 67 | 90 | 97 | 94 | 96 | 89 | 80 | 71 |
| Depreciation | 139 | 151 | 155 | 157 | 161 | 169 | 186 | 188 | 194 | 194 | 195 | 203 | 212 |
| Profit before tax | 618 | 631 | 733 | 486 | 415 | 348 | 443 | 344 | 284 | 369 | 707 | 576 | 517 |
| Tax % | 22% | 19% | 23% | 26% | 27% | 27% | 5% | 27% | 29% | 26% | 26% | 25% | 25% |
| Net Profit | 481 | 511 | 562 | 359 | 301 | 253 | 422 | 252 | 201 | 271 | 526 | 432 | 388 |
| EPS in Rs | 16.23 | 17.24 | 18.97 | 12.12 | 10.15 | 8.55 | 14.24 | 8.51 | 6.79 | 9.14 | 17.75 | 14.58 | 13.10 |
Last Updated: December 29, 2025, 1:33 am
Below is a detailed analysis of the quarterly data for SRF Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,640.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,819.00 Cr. (Jun 2025) to 3,640.00 Cr., marking a decrease of 179.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,866.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,989.00 Cr. (Jun 2025) to 2,866.00 Cr., marking a decrease of 123.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 774.00 Cr.. The value appears to be declining and may need further review. It has decreased from 830.00 Cr. (Jun 2025) to 774.00 Cr., marking a decrease of 56.00 Cr..
- For OPM %, as of Sep 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Jun 2025) to 21.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Jun 2025) to 26.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 71.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 80.00 Cr. (Jun 2025) to 71.00 Cr., marking a decrease of 9.00 Cr..
- For Depreciation, as of Sep 2025, the value is 212.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 203.00 Cr. (Jun 2025) to 212.00 Cr., marking an increase of 9.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 517.00 Cr.. The value appears to be declining and may need further review. It has decreased from 576.00 Cr. (Jun 2025) to 517.00 Cr., marking a decrease of 59.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 388.00 Cr.. The value appears to be declining and may need further review. It has decreased from 432.00 Cr. (Jun 2025) to 388.00 Cr., marking a decrease of 44.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 13.10. The value appears to be declining and may need further review. It has decreased from 14.58 (Jun 2025) to 13.10, marking a decrease of 1.48.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,018 | 4,540 | 4,593 | 4,822 | 5,589 | 7,100 | 7,209 | 8,400 | 12,434 | 14,870 | 13,139 | 14,693 | 15,263 |
| Expenses | 3,513 | 3,822 | 3,630 | 3,852 | 4,683 | 5,803 | 5,754 | 6,267 | 9,330 | 11,341 | 10,554 | 11,975 | 12,082 |
| Operating Profit | 505 | 717 | 963 | 969 | 906 | 1,297 | 1,455 | 2,133 | 3,103 | 3,529 | 2,584 | 2,718 | 3,181 |
| OPM % | 13% | 16% | 21% | 20% | 16% | 18% | 20% | 25% | 25% | 24% | 20% | 18% | 21% |
| Other Income | 24 | 65 | 28 | 73 | 115 | 78 | 152 | 66 | 116 | 75 | 83 | 133 | 129 |
| Interest | 96 | 138 | 130 | 102 | 124 | 198 | 201 | 134 | 116 | 205 | 302 | 376 | 336 |
| Depreciation | 225 | 245 | 275 | 283 | 316 | 358 | 389 | 453 | 517 | 575 | 673 | 772 | 805 |
| Profit before tax | 208 | 399 | 585 | 657 | 582 | 818 | 1,018 | 1,612 | 2,586 | 2,824 | 1,692 | 1,704 | 2,169 |
| Tax % | 22% | 24% | 27% | 22% | 21% | 22% | -0% | 26% | 27% | 23% | 21% | 27% | |
| Net Profit | 162 | 303 | 430 | 515 | 462 | 642 | 1,019 | 1,198 | 1,889 | 2,162 | 1,336 | 1,251 | 1,618 |
| EPS in Rs | 5.66 | 10.55 | 14.97 | 17.94 | 16.08 | 22.33 | 35.46 | 40.44 | 63.72 | 72.95 | 45.06 | 42.20 | 54.57 |
| Dividend Payout % | 36% | 19% | 14% | 14% | 15% | 11% | 8% | 12% | 26% | 10% | 16% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 87.04% | 41.91% | 19.77% | -10.29% | 38.96% | 58.72% | 17.57% | 57.68% | 14.45% | -38.21% | -6.36% |
| Change in YoY Net Profit Growth (%) | 0.00% | -45.12% | -22.15% | -30.06% | 49.25% | 19.76% | -41.16% | 40.11% | -43.23% | -52.66% | 31.84% |
SRF Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 6% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 4% |
| 3 Years: | -13% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 28% |
| 3 Years: | 3% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 15% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:01 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 60 | 297 | 297 | 297 | 297 | 297 |
| Reserves | 2,008 | 2,238 | 2,705 | 3,124 | 3,506 | 4,071 | 4,875 | 6,796 | 8,268 | 10,030 | 11,182 | 12,329 | 12,966 |
| Borrowings | 2,175 | 2,435 | 2,515 | 2,396 | 3,142 | 3,730 | 4,135 | 3,469 | 3,655 | 4,478 | 5,031 | 4,726 | 4,605 |
| Other Liabilities | 1,227 | 1,152 | 1,146 | 1,389 | 1,657 | 2,028 | 1,795 | 2,586 | 3,544 | 3,931 | 3,945 | 4,169 | 4,393 |
| Total Liabilities | 5,469 | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 22,261 |
| Fixed Assets | 3,551 | 3,922 | 4,113 | 4,405 | 5,122 | 5,609 | 6,368 | 7,827 | 8,425 | 10,050 | 13,242 | 13,720 | 13,932 |
| CWIP | 112 | 104 | 117 | 259 | 559 | 754 | 1,393 | 772 | 1,672 | 2,406 | 805 | 811 | 1,238 |
| Investments | 37 | 94 | 165 | 196 | 122 | 101 | 203 | 417 | 321 | 494 | 527 | 827 | 537 |
| Other Assets | 1,769 | 1,762 | 2,029 | 2,109 | 2,561 | 3,424 | 2,899 | 3,895 | 5,347 | 5,786 | 5,881 | 6,163 | 6,555 |
| Total Assets | 5,469 | 5,883 | 6,424 | 6,968 | 8,363 | 9,888 | 10,862 | 12,911 | 15,765 | 18,736 | 20,454 | 21,521 | 22,261 |
Below is a detailed analysis of the balance sheet data for SRF Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 297.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 297.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,966.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,329.00 Cr. (Mar 2025) to 12,966.00 Cr., marking an increase of 637.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4,605.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4,726.00 Cr. (Mar 2025) to 4,605.00 Cr., marking a decrease of 121.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,393.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,169.00 Cr. (Mar 2025) to 4,393.00 Cr., marking an increase of 224.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 22,261.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21,521.00 Cr. (Mar 2025) to 22,261.00 Cr., marking an increase of 740.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 13,932.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,720.00 Cr. (Mar 2025) to 13,932.00 Cr., marking an increase of 212.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,238.00 Cr.. The value appears strong and on an upward trend. It has increased from 811.00 Cr. (Mar 2025) to 1,238.00 Cr., marking an increase of 427.00 Cr..
- For Investments, as of Sep 2025, the value is 537.00 Cr.. The value appears to be declining and may need further review. It has decreased from 827.00 Cr. (Mar 2025) to 537.00 Cr., marking a decrease of 290.00 Cr..
- For Other Assets, as of Sep 2025, the value is 6,555.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,163.00 Cr. (Mar 2025) to 6,555.00 Cr., marking an increase of 392.00 Cr..
- For Total Assets, as of Sep 2025, the value is 22,261.00 Cr.. The value appears strong and on an upward trend. It has increased from 21,521.00 Cr. (Mar 2025) to 22,261.00 Cr., marking an increase of 740.00 Cr..
Notably, the Reserves (12,966.00 Cr.) exceed the Borrowings (4,605.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 503.00 | 715.00 | 961.00 | 967.00 | 903.00 | -2.00 | -3.00 | -1.00 | 0.00 | -1.00 | -3.00 | -2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 49 | 41 | 50 | 44 | 53 | 45 | 55 | 53 | 44 | 54 | 54 |
| Inventory Days | 114 | 110 | 105 | 126 | 115 | 113 | 119 | 133 | 129 | 112 | 127 | 111 |
| Days Payable | 120 | 83 | 112 | 122 | 126 | 127 | 110 | 144 | 126 | 110 | 120 | 111 |
| Cash Conversion Cycle | 56 | 75 | 34 | 54 | 34 | 38 | 54 | 45 | 55 | 46 | 61 | 55 |
| Working Capital Days | 19 | 10 | 1 | -15 | -21 | -17 | -37 | -14 | 1 | -6 | -18 | -9 |
| ROCE % | 8% | 11% | 14% | 14% | 11% | 14% | 14% | 18% | 24% | 22% | 13% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Flexicap Fund | 6,250,000 | 3.22 | 1829.56 | N/A | N/A | N/A |
| Kotak Midcap Fund | 4,057,530 | 1.96 | 1187.76 | 3,807,530 | 2025-12-15 01:56:57 | 6.57% |
| Kotak Large & Midcap Fund | 1,750,000 | 1.71 | 512.28 | N/A | N/A | N/A |
| HDFC Large Cap Fund | 1,388,025 | 1 | 406.32 | N/A | N/A | N/A |
| Aditya Birla Sun Life Flexi Cap Fund | 1,150,000 | 1.36 | 336.64 | N/A | N/A | N/A |
| Mirae Asset Large & Midcap Fund | 853,792 | 0.57 | 249.93 | 1,216,956 | 2025-12-08 05:14:22 | -29.84% |
| Nippon India Multi Cap Fund | 825,862 | 0.48 | 241.75 | N/A | N/A | N/A |
| Kotak Multicap Fund | 768,216 | 1.01 | 224.88 | N/A | N/A | N/A |
| Mirae Asset Midcap Fund | 646,870 | 1.03 | 189.36 | N/A | N/A | N/A |
| HDFC Large and Mid Cap Fund | 620,090 | 0.63 | 181.52 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 42.20 | 45.06 | 72.95 | 63.75 | 40.57 |
| Diluted EPS (Rs.) | 42.20 | 45.06 | 72.95 | 63.75 | 40.57 |
| Cash EPS (Rs.) | 67.99 | 67.52 | 92.04 | 80.89 | 273.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 424.50 | 385.93 | 347.20 | 287.97 | 1137.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 424.50 | 385.93 | 347.20 | 287.97 | 1137.81 |
| Revenue From Operations / Share (Rs.) | 493.98 | 441.72 | 499.94 | 418.02 | 1393.97 |
| PBDIT / Share (Rs.) | 95.86 | 89.67 | 121.17 | 108.21 | 365.03 |
| PBIT / Share (Rs.) | 69.92 | 67.06 | 101.83 | 90.82 | 289.84 |
| PBT / Share (Rs.) | 57.28 | 56.89 | 94.94 | 86.93 | 267.62 |
| Net Profit / Share (Rs.) | 42.05 | 44.91 | 72.70 | 63.51 | 198.79 |
| NP After MI And SOA / Share (Rs.) | 42.05 | 44.91 | 72.70 | 63.51 | 198.79 |
| PBDIT Margin (%) | 19.40 | 20.30 | 24.23 | 25.88 | 26.18 |
| PBIT Margin (%) | 14.15 | 15.18 | 20.36 | 21.72 | 20.79 |
| PBT Margin (%) | 11.59 | 12.87 | 18.99 | 20.79 | 19.19 |
| Net Profit Margin (%) | 8.51 | 10.16 | 14.54 | 15.19 | 14.26 |
| NP After MI And SOA Margin (%) | 8.51 | 10.16 | 14.54 | 15.19 | 14.26 |
| Return on Networth / Equity (%) | 9.90 | 11.63 | 20.93 | 22.05 | 17.47 |
| Return on Capital Employeed (%) | 12.89 | 13.29 | 21.88 | 23.83 | 18.66 |
| Return On Assets (%) | 5.80 | 6.52 | 11.52 | 11.97 | 9.26 |
| Long Term Debt / Equity (X) | 0.15 | 0.19 | 0.22 | 0.20 | 0.28 |
| Total Debt / Equity (X) | 0.36 | 0.42 | 0.42 | 0.41 | 0.42 |
| Asset Turnover Ratio (%) | 0.69 | 0.66 | 0.86 | 0.76 | 0.64 |
| Current Ratio (X) | 1.13 | 1.03 | 1.17 | 1.18 | 1.10 |
| Quick Ratio (X) | 0.69 | 0.60 | 0.71 | 0.70 | 0.69 |
| Inventory Turnover Ratio (X) | 6.29 | 2.91 | 3.23 | 2.95 | 2.64 |
| Dividend Payout Ratio (NP) (%) | 17.06 | 15.97 | 9.87 | 11.21 | 11.79 |
| Dividend Payout Ratio (CP) (%) | 10.55 | 10.62 | 7.79 | 8.80 | 8.55 |
| Earning Retention Ratio (%) | 82.94 | 84.03 | 90.13 | 88.79 | 88.21 |
| Cash Earning Retention Ratio (%) | 89.45 | 89.38 | 92.21 | 91.20 | 91.45 |
| Interest Coverage Ratio (X) | 7.58 | 8.82 | 17.60 | 27.76 | 16.42 |
| Interest Coverage Ratio (Post Tax) (X) | 4.33 | 5.42 | 11.56 | 17.29 | 9.95 |
| Enterprise Value (Cr.) | 91715.52 | 80584.47 | 75307.61 | 82747.82 | 35228.28 |
| EV / Net Operating Revenue (X) | 6.24 | 6.13 | 5.06 | 6.66 | 4.19 |
| EV / EBITDA (X) | 32.17 | 30.21 | 20.89 | 25.71 | 16.02 |
| MarketCap / Net Operating Revenue (X) | 5.95 | 5.79 | 4.81 | 6.41 | 3.88 |
| Retention Ratios (%) | 82.93 | 84.02 | 90.12 | 88.78 | 88.20 |
| Price / BV (X) | 6.92 | 6.63 | 6.93 | 9.30 | 4.75 |
| Price / Net Operating Revenue (X) | 5.95 | 5.79 | 4.81 | 6.41 | 3.88 |
| EarningsYield | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 |
After reviewing the key financial ratios for SRF Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has decreased from 45.06 (Mar 24) to 42.20, marking a decrease of 2.86.
- For Diluted EPS (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has decreased from 45.06 (Mar 24) to 42.20, marking a decrease of 2.86.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.99. This value is within the healthy range. It has increased from 67.52 (Mar 24) to 67.99, marking an increase of 0.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 424.50. It has increased from 385.93 (Mar 24) to 424.50, marking an increase of 38.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 424.50. It has increased from 385.93 (Mar 24) to 424.50, marking an increase of 38.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 493.98. It has increased from 441.72 (Mar 24) to 493.98, marking an increase of 52.26.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.86. This value is within the healthy range. It has increased from 89.67 (Mar 24) to 95.86, marking an increase of 6.19.
- For PBIT / Share (Rs.), as of Mar 25, the value is 69.92. This value is within the healthy range. It has increased from 67.06 (Mar 24) to 69.92, marking an increase of 2.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 57.28. This value is within the healthy range. It has increased from 56.89 (Mar 24) to 57.28, marking an increase of 0.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 42.05. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.05, marking a decrease of 2.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 42.05. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.05, marking a decrease of 2.86.
- For PBDIT Margin (%), as of Mar 25, the value is 19.40. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 19.40, marking a decrease of 0.90.
- For PBIT Margin (%), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 15.18 (Mar 24) to 14.15, marking a decrease of 1.03.
- For PBT Margin (%), as of Mar 25, the value is 11.59. This value is within the healthy range. It has decreased from 12.87 (Mar 24) to 11.59, marking a decrease of 1.28.
- For Net Profit Margin (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has decreased from 10.16 (Mar 24) to 8.51, marking a decrease of 1.65.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has decreased from 10.16 (Mar 24) to 8.51, marking a decrease of 1.65.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.90. This value is below the healthy minimum of 15. It has decreased from 11.63 (Mar 24) to 9.90, marking a decrease of 1.73.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.89. This value is within the healthy range. It has decreased from 13.29 (Mar 24) to 12.89, marking a decrease of 0.40.
- For Return On Assets (%), as of Mar 25, the value is 5.80. This value is within the healthy range. It has decreased from 6.52 (Mar 24) to 5.80, marking a decrease of 0.72.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 24) to 0.15, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.36, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has increased from 0.66 (Mar 24) to 0.69, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.13, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.69, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.29. This value is within the healthy range. It has increased from 2.91 (Mar 24) to 6.29, marking an increase of 3.38.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.06. This value is below the healthy minimum of 20. It has increased from 15.97 (Mar 24) to 17.06, marking an increase of 1.09.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.55. This value is below the healthy minimum of 20. It has decreased from 10.62 (Mar 24) to 10.55, marking a decrease of 0.07.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.94. This value exceeds the healthy maximum of 70. It has decreased from 84.03 (Mar 24) to 82.94, marking a decrease of 1.09.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.45. This value exceeds the healthy maximum of 70. It has increased from 89.38 (Mar 24) to 89.45, marking an increase of 0.07.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.58. This value is within the healthy range. It has decreased from 8.82 (Mar 24) to 7.58, marking a decrease of 1.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has decreased from 5.42 (Mar 24) to 4.33, marking a decrease of 1.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91,715.52. It has increased from 80,584.47 (Mar 24) to 91,715.52, marking an increase of 11,131.05.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.24. This value exceeds the healthy maximum of 3. It has increased from 6.13 (Mar 24) to 6.24, marking an increase of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 32.17. This value exceeds the healthy maximum of 15. It has increased from 30.21 (Mar 24) to 32.17, marking an increase of 1.96.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has increased from 5.79 (Mar 24) to 5.95, marking an increase of 0.16.
- For Retention Ratios (%), as of Mar 25, the value is 82.93. This value exceeds the healthy maximum of 70. It has decreased from 84.02 (Mar 24) to 82.93, marking a decrease of 1.09.
- For Price / BV (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 3. It has increased from 6.63 (Mar 24) to 6.92, marking an increase of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has increased from 5.79 (Mar 24) to 5.95, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in SRF Ltd:
- Net Profit Margin: 8.51%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.89% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.9% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 56.1 (Industry average Stock P/E: 33.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.51%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Unit Nos. 236 & 237, 2nd Floor, DLF Galleria, Mayur Place, Delhi Delhi 110091 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Bharat Ram | Chairman Emeritus |
| Mr. Ashish Bharat Ram | Chairman & Managing Director |
| Mr. Kartik Bharat Ram | Joint Managing Director |
| Mr. Pramod G Gujarathi | Director |
| Mr. Vellayan Subbiah | Non Exe.Non Ind.Director |
| Ms. Bharti Gupta Ramola | Independent Director |
| Mr. Puneet Yadu Dalmia | Independent Director |
| Mr. Yash Gupta | Independent Director |
| Mr. Raj Kumar Jain | Independent Director |
| Ms. Ira Gupta | Independent Director |
| Mr. Vineet Agarwal | Independent Director |
FAQ
What is the intrinsic value of SRF Ltd?
SRF Ltd's intrinsic value (as of 05 January 2026) is ₹2091.39 which is 31.65% lower the current market price of ₹3,060.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹90,691 Cr. market cap, FY2025-2026 high/low of ₹3,325/2,260, reserves of ₹12,966 Cr, and liabilities of ₹22,261 Cr.
What is the Market Cap of SRF Ltd?
The Market Cap of SRF Ltd is 90,691 Cr..
What is the current Stock Price of SRF Ltd as on 05 January 2026?
The current stock price of SRF Ltd as on 05 January 2026 is ₹3,060.
What is the High / Low of SRF Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of SRF Ltd stocks is ₹3,325/2,260.
What is the Stock P/E of SRF Ltd?
The Stock P/E of SRF Ltd is 56.1.
What is the Book Value of SRF Ltd?
The Book Value of SRF Ltd is 447.
What is the Dividend Yield of SRF Ltd?
The Dividend Yield of SRF Ltd is 0.24 %.
What is the ROCE of SRF Ltd?
The ROCE of SRF Ltd is 12.3 %.
What is the ROE of SRF Ltd?
The ROE of SRF Ltd is 10.4 %.
What is the Face Value of SRF Ltd?
The Face Value of SRF Ltd is 10.0.